Relationship between markers of insulin resistance, markers of adiposity, HbA1c, and cognitive functions in a middle-aged population-based sample: The MONA LISA study

Diabetes Care

Volumn 36, Issue 6, 2013, Pages 1512-1521

  Sanz, Caroline M ^a,b   Ruidavets, Jean Bernard ^a,b   Bongard, Vanina ^a,b   Marquié, Jean Claude ^c   Hanaire, Hélène ^b   Ferrières, Jean ^a,b   Andrieu, Sandrine ^a,b  

^a Faculté de Médecine Centre Hospitalo universitaire   (France)

^b TOULOUSE UNIVERSITY HOSPITAL   (France)

^c PSL RESEARCH UNIVERSITY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; HEMOGLOBIN A1C; PSYCHOTROPIC AGENT;

ADULT; AGE; ALCOHOL CONSUMPTION; ARTICLE; ATTENTION; BODY FAT; BODY MASS; COGNITION; CONTROLLED STUDY; DEPRESSION; DIGIT SYMBOL SUBSTITUTION TEST; DISEASE ASSOCIATION; DISEASE MARKER; DRUG ABUSE; DYSLIPIDEMIA; EDUCATIONAL STATUS; FEMALE; GENDER; HOMEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE; HUMAN; HYPERTENSION; INCOME; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MEMORY; METABOLIC SYNDROME X; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NEUROPSYCHOLOGICAL TEST; OBESITY; OCCUPATION; SEDENTARY LIFESTYLE; SMOKING; STROOP TEST; VASCULAR DISEASE; WAIST CIRCUMFERENCE; WORD FLUENCY TEST; WORD LIST LEARNING TEST;

ADIPOSITY; ADULT; COGNITION; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN RESISTANCE; LOGISTIC MODELS; MALE; MIDDLE AGED; SEX FACTORS; WAIST CIRCUMFERENCE;

EID: 84878261427     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc12-1017     Document Type: Article

References (36)

1. Singh-Manoux A, Kivimaki M, Glymour MM, et al. Timing of onset of cognitive decline: results from Whitehall II prospective cohort study. BMJ 2012;344:d7622
2. Stern Y. What is cognitive reserve? Theory and research application of the reserve concept. J Int Neuropsychol Soc 2002;8:448-460 (Pubitemid 34296102)
3. Ferri CP, Prince M, Brayne C, et al.; Alzheimer's Disease International. Global prevalence of dementia: a Delphi consensus study. Lancet 2005;366:2112-2117 (Pubitemid 41797645)
4. Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E. Alzheimer's disease. Lancet 2011;377:1019-1031
5. Coley N, Andrieu S, Gardette V, et al. Dementia prevention: methodological explanations for inconsistent results. Epidemiol Rev 2008;30:35-66
6. Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol 2006;5:64-74 (Pubitemid 41790697)
7. Launer LJ, Miller ME, Williamson JD, et al.; ACCORD MIND investigators. Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy. Lancet Neurol 2011;10:969-977
8. Mather KJ, Hunt AE, Steinberg HO, et al. Repeatability characteristics of simple indices of insulin resistance: implications for research applications. J Clin Endocrinol Metab 2001;86:5457-5464 (Pubitemid 33070275)
9. Katsuki A, Sumida Y, Urakawa H, et al. Neither homeostasis model assessment nor quantitative insulin sensitivity check index can predict insulin resistance in elderly patients with poorly controlled type 2 diabetes mellitus. J Clin Endocrinol Metab 2002;87:5332-5335 (Pubitemid 35316381)
10. McAuley KA,Williams SM, Mann JI, et al. Diagnosing insulin resistance in the general population. Diabetes Care 2001;24:460-464 (Pubitemid 32198413)
11. American Diabetes Association. Standards of medical care in diabetes - 2011. Diabetes Care 2011;34(Suppl. 1):S11-S61
12. Rey A. Clinical Tests in Psychology . Paris, Presses Universitaires de France, 1964 [in French]
13. Wechsler D. Manual for the Wechsler Adult Intelligence Scale. New York, Psychological Corporation, 1955
14. Stroop J. Studies of interference in serial verbal reactions. J Exp Psychol 1935;18:643-662
15. Salthouse TA. The processing-speed theory of adult age differences in cognition. Psychol Rev 1996;103:403-428 (Pubitemid 126432206)
16. Efron B, Gong G. A leisurely look at the bootstrap, the jackknife, and cross-validation. Am Stat 1983;37:36-48
17. Cournot M, Marquié JC, Ansiau D, et al. Relation between body mass index and cognitive function in healthy middle-aged men and women. Neurology 2006;67:1208-1214 (Pubitemid 44563829)
18. Tan ZS, Beiser AS, FoxCS, et al. Association of metabolic dysregulation with volumetric brain magnetic resonance imaging and cognitive markers of subclinical brain aging in middle-aged adults: the Framingham Offspring Study. Diabetes Care 2011;34:1766-1770
19. Young SE, Mainous AG 3rd, Carnemolla M. Hyperinsulinemia and cognitive decline in a middle-aged cohort. Diabetes Care 2006;29:2688-2693 (Pubitemid 44912200)
20. Park DC, Lautenschlager G, Hedden T, Davidson NS, Smith AD, Smith PK. Models of visuospatial and verbal memory across the adult life span. Psychol Aging 2002;17:299-320 (Pubitemid 34568644)
21. Jacobson AM, Musen G, Ryan CM, et al.; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Research Group. Long-term effect of diabetes and its treatment on cognitive function. N Engl J Med 2007;356:1842-1852 (Pubitemid 46698465)
22. Amieva H, Le Goff M, Millet X, et al. Prodromal Alzheimer's disease: successive emergence of the clinical symptoms. Ann Neurol 2008;64:492-498
23. Craft S. The role of metabolic disorders in Alzheimer disease and vascular dementia: two roads converged. Arch Neurol 2009;66:300-305
24. Poirier P, Giles TD, Bray GA, et al.; American Heart Association; Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 2006;113:898-918
25. Hamel FG, Upward JL, Bennett RG. In vitro inhibition of insulin-degrading enzyme by long-chain fatty acids and their coenzyme A thioesters. Endocrinology 2003;144:2404-2408 (Pubitemid 36629891)
26. Gamblin TC, KingME, Kuret J, Berry RW, Binder LI. Oxidative regulation of fatty acid-induced tau polymerization. Biochemistry 2000;39:14203-14210
27. Grundy SM, Cleeman JI, Daniels SR, et al.; American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112:2735-2752 (Pubitemid 41532612)
28. Goodpaster BH, Krishnaswami S, Harris TB, et al. Obesity, regional body fat distribution, and the metabolic syndrome in older men and women. Arch Intern Med 2005;165:777-783 (Pubitemid 40569431)
29. Whitmer RA, Quesenberry CP, Zhou J, Yaffe K. Timing of hormone therapy and dementia: the critical window theory revisited. Ann Neurol 2011;69:163-169
30. Cheng YJ, Gregg EW, Geiss LS, et al. Association of A1C and fasting plasma glucose levels with diabetic retinopathy prevalence in the U.S. population: implications for diabetes diagnostic thresholds. Diabetes Care 2009;32:2027-2032
31. Kawasaki R, Cheung N, Mosley T, et al. Retinal microvascular signs and 10-year risk of cerebral atrophy: the Atherosclerosis Risk in Communities (ARIC) study. Stroke 2010;41:1826-1828
32. Wong TY, Klein R, Sharrett AR, et al. Retinal microvascular abnormalities and cognitive impairment in middle-aged persons: the Atherosclerosis Risk in Communities Study. Stroke 2002;33:1487-1492 (Pubitemid 34619944)
33. Li G, Zhang P, Wang J, et al. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet 2008;371:1783-1789 (Pubitemid 351697954)
34. Lindström J, Ilanne-Parikka P, Peltonen M, et al.; Finnish Diabetes Prevention Study Group. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet 2006;368:1673-1679 (Pubitemid 46048554)
35. Sanz C, Gautier JF, Hanaire H. Physical exercise for the prevention and treatment of type 2 diabetes. Diabetes Metab 2010;36:346-351
36. Knowler WC, Narayan KM, Hanson RL, et al. Preventing non-insulin- dependent diabetes. Diabetes 1995;44:483-488